DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Phenglutarimide

Phenglutarimide

  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017

    Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017

  • (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al

    (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al

  • Pharmacy and Poisons Act 1979

    Pharmacy and Poisons Act 1979

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent:

    United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent: "Aug

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

    BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

  • Page 1 FINLANDS FÖRFATTNINGSSAMLING Utgiven I Helsingfors

    Page 1 FINLANDS FÖRFATTNINGSSAMLING Utgiven I Helsingfors

  • Medicines Regulations 1984 (SR 1984/143)

    Medicines Regulations 1984 (SR 1984/143)

  • Botulinum Toxin

    Botulinum Toxin

  • WO 2014/006004 Al 9 January 2014 (09.01.2014) P O P C T

    WO 2014/006004 Al 9 January 2014 (09.01.2014) P O P C T

  • Medicines (Prescription Only) (Jersey) Order 1997

    Medicines (Prescription Only) (Jersey) Order 1997

  • Council of Europe Committee of Ministers (Partial

    Council of Europe Committee of Ministers (Partial

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • Stereoselective Inhibition of Muscarinic Receptor Subtypes by the Enantiomers of Hexahydro-Difenidol and Acetylenic Analogues

    Stereoselective Inhibition of Muscarinic Receptor Subtypes by the Enantiomers of Hexahydro-Difenidol and Acetylenic Analogues

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agent

    Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agent

Top View
  • I Mechanistically Distinct Modes of Endocannabinoid Mobilization At
  • Review of the Square Box Symbol Uses
  • 2U11/148243 Al
  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
  • Pharmacological Investigations on Muscarinic and P2 Receptor Subtypes
  • Muscarinic Acetylcholine Receptor
  • (12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
  • The Calculation of Physicochemical Descriptors and Their Application in Predicting Properties of Drugs and Other Compounds
  • Customs Tariff - Schedule Xxi - 1
  • (12) United States Patent (10) Patent No.: US 9,358,295 B2 Tygesen Et Al
  • Method for Producing Monolithic Tablets
  • 1.2 Histamine Receptors
  • Literature Search Strategy for Treatment of Stable
  • ( 12 ) United States Patent
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • ICD-10-CM TABLE of DRUGS and CHEMICALS
  • Anti-Parkinsonian Apis and Impurities Amantadine Hydrochloride


© 2024 Docslib.org    Feedback